Skip to content

Citrullinemia Type I C4721769

Published: July 22, 2026Updated: August 25, 2026

A metabolic disorder where the body cannot properly break down certain amino acids from proteins. This causes harmful substances to build up, affecting the brain and nervous system. It is managed through a strict low-protein diet and medications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hyperammonemia

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Vomiting

(gastrointestinal)

Lethargy

(neurologic)

Hepatomegaly

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Strict Protein-Restricted Diet

Lifelong dietary management restricting natural protein intake while ensuring adequate calories and essential nutrients. Calculated using gram-per-kilogram formulas individualized to each patient based on enzyme activity levels and growth requirements.

dietary
3

Nitrogen Scavenger Therapy

Ammonia-lowering medications such as sodium phenylbutyrate or sodium benzoate that provide alternative pathways for nitrogen excretion. Dosing is titrated based on plasma amino acid and ammonia levels.

medication

Additional treatment options

Metabolic Crisis Prevention Protocol

Frequent plasma amino acid analysis and ammonia monitoring with sick-day protocols for illness, surgery, or stress. Home ammonia testing enables early detection of hyperammonemic episodes requiring urgent intervention.

monitoring

Specialized Amino Acid Formulas

Protein substitute formulas providing essential amino acids without nitrogen load, supplemented with vitamins, minerals, and carnitine. Essential for preventing deficiencies and supporting normal growth and metabolism.

dietary

Liver Transplantation for Severe Disease

Orthotopic liver transplantation for patients with severe neonatal citrullinemia or recurrent hyperammonemic crises despite optimal medical therapy. Provides enzyme replacement and corrects urea cycle dysfunction.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Citrullinemia Type I C4721769?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Häberle J, Burlina A, Chakrapani A, et al. Clinical practice guidelines for the management of urea cycle disorders. J Inherit Metab Dis. 2019.

guideline2019
2

Seminara J, Rodriguez-Buritica DF, Enns GM, et al. Diagnosis and management of citrullinemia type I: a review of current perspectives. Orphanet J Rare Dis. 2021.

review2021
3

Tortorelli S, Keener CL, Braverman NE, et al. Newborn screening for citrullinemia type I: a multi-center evaluation of screening algorithms and outcomes. Mol Genet Metab. 2020.

clinical_trial2020
4

Mazariego MR, Hernandez VM, Pena-Quintana L, et al. Nutritional management of citrullinemia type I: dietary approaches and long-term outcomes. Clin Nutr ESPEN. 2023.

review2023

Medication Comparisons

Compare medications used to treat Citrullinemia Type I C4721769. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy